Nutra Pharma Corp (NPHC)

[otcbbnpink]

It was a 1 for 40 r/s in March of 2015. After the split, there was about 40-45M shares out. The filings showed obligations to issue another 10-15M shares, so figure as much as 60M fully diluted.

The problem is that they put out a lot of convertible debt right after that and the stock has plummeted from a high of $0.27 in the summer of 2015 to a low of about $0.005 in the last month or so - - - with outstanding shares around 210M now - about 80M in the float.

All of this sounds depressing, but I think about 2 things when I look at future growth:

- In 2009, with a similar share structure, the stock hit $0.99 per share and stayed in the $0.70-$0.80 range. That was all on only about $500K in sales with Cobroxin hitting the market. Any sales growth of Nyloxin or Pet Pain-Away could see real growth.

- If they can just get that Phase II study underway, they could easily receive a valuation of $100-$150M, or at least $0.50 per share.

I'm still a true believer. I love their products and their technology makes sense. I think that we'll see appreciation soon. JMHO-GLTYA